| NOVARTIS N | 85.22 / -0.34% |
| Date/Time | 10/21 / 11:30 |
| Chg. / Chg.(%) | -0.29 / -0.34% |
| Bid | 85.21 / 965 |
| Ask | 85.23 / 208 |
| Open | 85.47 |
| Previous Close | 85.51 |
| High | 85.55 |
| Low | 84.91 |
| Volume [CHF] | 61,640,020.24 |
| Volume [Units] | 754,151 |
| Price fixings | 3182 |
| ISIN | CH0012005267 |
| Security | NOVN |
| Exchange | SIX Swiss Exchange |
| Type | Stock |
| Exchange | Last | Volume | |
|---|---|---|---|
| SIX Swiss Ex.. | 85.22 |  |
754,151 |
| London Inter.. | 85.27 | |
10,417 |
| Lang & Schwa.. | 77.260 | |
|
| Nasdaq Other.. | 86.0000 |  |
698 |
| Cboe Europe .. | 89.12 | 725,512 | |
| Cboe Europe .. | 89.12 | 520,892 | |
| Turquoise | 89.12 | |
146,333 |
| TradeGate | 80.000 | 16,350 | |
| Cboe Europe .. | 80.29 | 2,465 | |
| Frankfurt | 80.1600 | 1,589 | |
| Cboe Europe .. | 80.25 | 1,286 | |
| Borsa Italia.. | 79.20 | 1,042 | |
| Hamburg | 80.19 | 1,000 | |
| Stuttgart | 80.100 | 513 | |
| Turquoise | 80.28 | |
125 |
| München | 80.10 | 55 | |
| Berlin | 80.40 | 40 | |
| gettex | 80.160 | 20 | |
| Düsseldorf | 80.18 | 4 | |
| Hannover | 80.10 | 0 | |
| Borsa Italia.. | 75.00 | 36 | |
| EUREX | Options | ||
News
- Global Lymphopenia Therapeutics Market Report 2019-2023 with Sales Data for Acquired Lymphopenia & Inherited Lymphopenia Products
10:50 - GlobeNewswire - ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Novartis AG and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
09/25/2019 / 17:20 - GlobeNewswire - SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Novartis AG
09/23/2019 / 16:23 - GlobeNewswire - ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Novartis AG and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
09/18/2019 / 17:40 - GlobeNewswire - SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Novartis AG
09/13/2019 / 16:15 - GlobeNewswire
Real-time